FDAnews Drug Daily Bulletin

GSK Drug Halves Attacks in Hard-to-Treat Asthma

Aug. 20, 2012
A A
An experimental drug for treating severe asthma from GlaxoSmithKline nearly halved the number of attacks suffered by patients with a hard-to-treat form of the disease in a clinical study, boosting hopes for its commercial success.
Reuters